Southwest Airlines (LUV)

Total Costs & Expenses

$36.16B

TTM · Period ending: · USD

LUV logo

LUV Total Costs & Expenses

Latest reported$36.16B
LUV TTM Total Costs & Expenses ($679.80M → $36.16B)
High-resolution chart · PNG

LUV total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Southwest Airlines Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
36,158,000,000
29,032,000,000
27,903,000,000
27,635,000,000
27,236,000,000
27,154,000,000
27,091,000,000
27,162,000,000
27,737,000,000
27,313,000,000
26,599,000,000
25,867,000,000
25,197,000,000
24,614,000,000
23,942,000,000
22,797,000,000
21,096,000,000
19,217,000,000
17,061,000,000
14,069,000,000
12,394,000,000
11,652,000,000
10,373,000,000
12,864,000,000
14,748,000,000
16,364,000,000
19,170,000,000
19,470,000,000
19,289,000,000
19,246,000,000
19,075,000,000
18,759,000,000
18,376,000,000
18,057,000,000
17,803,000,000
17,723,000,000
17,452,000,000
17,438,000,000
17,030,000,000
16,664,000,000
16,385,000,000
16,034,000,000
15,952,000,000
15,704,000,000
15,761,000,000
15,854,000,000
16,064,000,000
16,381,000,000
16,416,000,000
16,385,000,000
16,359,000,000
16,422,000,000
16,461,000,000
16,564,000,000
16,510,000,000
16,465,000,000
16,344,000,000
16,172,000,000
15,945,000,000
14,965,000,000
13,902,000,000
12,653,000,000
11,529,000,000
11,116,000,000
10,763,000,000
10,570,000,000
10,258,000,000
10,089,000,000
10,209,000,000
10,370,000,000
10,541,000,000
10,576,000,000
10,276,000,000
9,808,000,000
9,399,000,000
9,071,000,000
8,808,000,000
8,552,000,000
8,344,000,000
8,151,000,000
7,873,000,000
7,533,000,000
7,174,000,000
6,835,000,000
6,547,000,000
6,289,000,000
6,120,000,000
5,976,000,000
5,846,000,000
5,731,000,000
5,587,000,000
5,454,000,000
5,360,706,000
5,292,565,000
5,201,566,000
5,104,201,000
4,992,025,000
4,934,305,000
4,913,227,000
4,924,052,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.